Counterfeit Drugs Problems and Solutions for the Indian Pharmaceutical Industry Introduction Counterfeit drugs have been around for much of the recent history of industrial-scale drug production in India and abroad. Although detailed data on counterfeit medicines are difficult to obtain by virtue of its very nature‚ a recent WHO report estimates the prevalence to be around 1% of sales in developed countries to over 10% in some developing countries1. The more important aspect of this global
Premium Pharmaceutical industry Authentication Pharmacology
business of Pharmaceutical companies:- Pharmaceutical companies are not especially big in terms of revenues‚ but they are very profitable. For instance‚ in 2001‚ Pfizer was ranked 127th in the world on total revenue (US$32·2 billion) but 7th in terms of profit.29 The pharmaceutical industry is the most profitable business sector‚ with an average 16·2% profit‚ ahead of financial companies (11·6%) and beverages (10%).30 However‚ net income growth has declined‚ and growth in the value of drug
Premium Pharmacology Profit Income
Safety Implementations Table of Contents 1 Abstract 4 2 Introduction 5 3 Safe Drug Development Process in Pharmaceutical Companies 6 4 Pharmaceutical Unit Operation Safety Measures 10 4.1 Weighing and dispensing 10 4.2 Charging and discharging 10 4.3 Liquid separations 10 4.4 Filtration 11 4.5 Compounding 11 4.6 Drying 11 5 Biosafety Levels 12 5.1 Level 1 12 5.2 Level 2 12 5.3 Level 3 12 5.4 Level 4 13 6 Personal Protective Equipment 13 6.1 What is PPE? 13 6.2 OSHA Standards
Premium Occupational safety and health Personal protective equipment Pharmaceutical industry
1. Introduction The purpose of this report is to critically assess current purchasing and supply management practices in pharmaceutical industry‚ while looking at such companies as “Pfizer Inc.” and “Eli Lilly and Company”. Globalization‚ technological advances and increased worldwide competition has led to more complex supply chains in the pharmaceutical industry. It is important to acknowledge the increased exposure of these supply chains to risk. ‘The purpose of risk management is to ensure that
Premium Management Supply chain management Risk management
Pharmaceutical Marketing Merck “Merck has gone beyond developing and selling prescription pharmaceuticals. It formed joint ventures in 1989 with Johnson & Johnson to sell over the-counter pharmaceuticals; in 1991 with DuPont to expand basic research‚ and in 2000 with Scherigng-Plough to develop and market new prescriptions medicines. In 1997‚ Merck and Rhone-Poulenc S.A. (now Sanofi-Aventis S.A.) combined animal health and poultry genetics business to form Merial Limited‚ a fully integrated
Premium Pharmaceutical industry Pharmacology Clinical trial
Beximco Pharmaceutical Ltd is the manufacturer and marketer of pharmaceutical product under chemical divisions of Beximco Group. Beximco Pharmaceuticals is one of the leading pharmaceutical companies in Bangladesh. It also is one of the biggest suppliers of pharmaceutical product of any Bangladeshi based company. BPL is the first Bangladeshi company to supply pharmaceutical product to Riffles Hospital the most prestigious hospital of Singapore. The study has been carried out with the following objectives:
Premium Marketing Pharmaceutical industry Pharmacology
Presentation on Beximco Pharmaceuticals Name of the presenters ~ Faisal Bin Kamal 2009-3-10-057 2010-1-10-145 2010-1-10-149 2010-1-40-052 ~ Quazi Aritra Reyan ~ Md. Nayeem Hossain ~ Tahrim Shahriar Background of the Company Beximco Pharmaceuticals (BPL) is a leading edge pharmaceutical company based in Dhaka‚ Bangladesh. BPL started its operation in 1980 and now have grown to become nation’s one of the leading pharmaceutical companies. ~ BPL supplies more than 10% of country’s
Premium Pharmaceutical industry Tax Balance sheet
ENVIRONMENTAL FACTORS AFFECTING INDUSTRY 1 I.1. PESTEL ANALYSIS 1 I.2. FIVE FORCES MODEL 3 II. IMPLICATIONS OF CHANGING BUSINESS ENVIRONMENT 4 III. USE AND LIMITATIONS OF TOOLS APPLIED 5 III.1. USE AND LIMITATIONS OF PESTEL 5 III.2. USE AND LIMITATIONS OF FIVE FORCES MODEL 6 SUMMARY 6 APPENDIX 1 8 APPENDIX 2 9 REFERENCES 10 INTRODUCTION The origin of the modern pharmaceutical industry can be traced to the late
Premium Strategic management Pharmaceutical industry Generic drug
Teva Pharmaceutical Industries‚ Ltd 1) External Environment: The Pharmaceutical Industry is dependent on political and legal conditions of general environment. In pharmaceutical industry we have two kind of medications which are generic or innovative. Innovative pharmaceutical industry success depends on the patent protection in the industry. For example‚ in United States innovative industry can have 10 to 12 years of patent protection life from the time that product is for sale in the
Premium Generic drug Pharmaceutical industry Food and Drug Administration
Sector briefing Pharmaceutical Opportunities in Bangladesh. WHY BANGLADESH? Pharmaceutical is one of the highest priority sectors in Bangladesh. With an annual twodigit growth rate the Bangladesh pharmaceutical industry is now heading towards self – sufficiency in meeting local demand. With over US$250 million investments in the pharmaceutical industry of Bangladesh the sector has emerged as the country’s most developed hi-tech one that contributes significantly to the national economy
Premium Pharmacology International trade Pharmaceutical industry